
Pharma Business - August 6, 2015
Novo Nordisk reports increased operating profit
Novo Nordisk increased operating profit in Danish kroner by 57 percent in the first six months of 2015 to DKK 26.3 billion. 16% local currency operating profit growth adjusted for the NNIT divestment Sales increased by 25% in Danish kroner and by 9% in local currencies to DKK 52.3 billion. Sales of Victoza® increased by 41% […]